Genomtec S.A. Logo

Genomtec S.A.

Develops mobile platforms for rapid, point-of-care molecular diagnostics.

GMT | WAR

Overview

Corporate Details

ISIN(s):
PLGNMTC00017
LEI:
259400ND13Y44ADMG554
Country:
Poland
Address:
WROCŁAW BIERUTOWSKA 57-59, 51-317 WROCŁAW

Description

Genomtec S.A. is a technology company specializing in the development of mobile platforms for rapid molecular diagnostics. The company's flagship product is Genomtec ID, a portable point-of-care system for genetic testing that combines the amplification and detection of specific DNA and RNA fragments. This technology enables fast and accurate analysis without requiring specialized laboratory infrastructure or personnel. A key application is the CE-IVD certified GenomtecID Respiratory Panel 5-Plex (RP5-PLEX), which detects viruses and bacteria causing respiratory tract infections. The company has also organized its core technologies, the Genomtec ID platform and the OncoSNAAT oncology project, into separate special purpose vehicles to facilitate strategic development and potential M&A processes.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 17:26
Aktualizacja informacji w sprawie strategicznych kierunków współpracy - Content…
Polish 1.1 KB
2025-12-11 14:27
Otrzymanie od Urzędu Patentowego w Stanach Zjednoczonych decyzji o udzieleniu o…
Polish 2.0 KB
2025-11-28 17:32
zal01_Genomtec_sprawozdanie_III_kw_2025.pdf
Polish 940.2 KB
2025-11-28 17:32
zal02_GENOMTEC_Pozostale_informacje_do_3Q2025.pdf
Polish 958.9 KB
2025-10-15 16:44
Otrzymanie od Europejskiego Urzędu Patentowego decyzji o udzieleniu patentu eur…
Polish 1.4 KB
2025-09-29 18:10
zal04_opinia_RN_do_stanowiska.pdf
Polish 154.5 KB
2025-09-29 18:10
zal05_Stanowisko_Zarzadu_do_zastrzezenia.pdf
Polish 144.6 KB
2025-09-29 18:10
zal03_genomtec_sprawozdanie_zarzadu_ip_2025_vfinal_signed_1.pdf
Polish 1.1 MB
2025-09-29 18:10
zal02_GENOMTEC_PSF_2025_MSR_Raport_z_przegladu_ost.pdf
Polish 420.3 KB
2025-09-29 18:10
zal01_genomtec_sf_06.2025_sig_signed.pdf
Polish 1.6 MB
2025-09-25 17:13
Otrzymanie od Europejskiego Urzędu Patentowego decyzji o udzieleniu patentu eur…
Polish 1.6 KB
2025-09-15 17:12
Otrzymanie od Urzędu Patentowego w Japonii decyzji o udzieleniu ochrony patento…
Polish 2.0 KB
2025-09-15 17:08
Podjęcie przez Zarząd Giełdy Papierów Wartościowych uchwały w sprawie dopuszcze…
Polish 1.0 KB
2025-09-11 17:57
Przyznanie akcji w ramach warunkowego podwyższenia kapitału zakładowegoPrzyznan…
Polish 2.3 KB
2025-08-14 17:28
Przyznanie akcji w ramach warunkowego podwyższenia kapitału zakładowego - Conte…
Polish 2.2 KB

Automate Your Workflow. Get a real-time feed of all Genomtec S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomtec S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomtec S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.